PATENT CLAIM ANALYSIS

Application Number: 16183593
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "489000"]

Abstract:
The present invention provides ophthalmic formulations containing cyclosporine, methods for preparing the formulation, and methods for using the formulation.

Claim (Index 61):
A method for preparing the nanoemulsion formulation of the cyclosporine of  claim 35 , comprising:\n (f) dissolving a cyclosporine in a mixture of (i) at least one oil, (ii) at least one solvent, and (iii) at least one surfactant to form an emulsion pre-mix, (g) adding an aqueous phase to the emulsion pre-mix, and (h) homogenizing or vigorously stirring the mixture of step (b), wherein the cyclosporine is precipitated into particles and solubilized in the at least one oil and the aqueous phase.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 98.0
- Lexical Diversity: 1.29412
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12007902', '14623150', '15142709', '15546205', '11363379']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7319111525178064
- 35 USC 102 Novelty (BERT): 0.5528184153733336
- Combined Prediction Score: 0.7140018788033592
- Mean Citation Score: 248.336942
- Max Citation Score: 435.34525
- Similarity Product: 330.13058345976475

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test